Join soligenix's exclusive live investor webinar and q&a session on september 18, 2024

Princeton, n.j. , sept. 16, 2024 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, is pleased to invite investors to a webinar on september 18, 2024, at 4:15 p.m.

SNGX Ratings Summary

SNGX Quant Ranking